177 related articles for article (PubMed ID: 17926482)
21. Comparative efficiency of diagnostics and treatment for Helicobacter pylori infection in children.
Niankovskiĭ S; Ivakhnenko O
Georgian Med News; 2008 Mar; (156):32-9. PubMed ID: 18403807
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori and non-malignant diseases.
Shirin H; Leja M; Niv Y
Helicobacter; 2008 Oct; 13 Suppl 1():23-7. PubMed ID: 18783518
[TBL] [Abstract][Full Text] [Related]
23. Evolution of the management of Helicobacter pylori infection in general practice.
Tosetti C
Helicobacter; 2006 Jun; 11(3):208-10. PubMed ID: 16684269
[No Abstract] [Full Text] [Related]
24. Statistical annex: statistical aspects of clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group.
Gut; 1997 Sep; 41 Suppl 2():S19-23. PubMed ID: 9404238
[No Abstract] [Full Text] [Related]
25. Treatment of Helicobacter pylori infection.
Egan BJ; Marzio L; O'Connor H; O'Morain C
Helicobacter; 2008 Oct; 13 Suppl 1():35-40. PubMed ID: 18783520
[TBL] [Abstract][Full Text] [Related]
26. Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori.
Suzuki S; Suzuki H; Nishizawa T; Kaneko F; Ootani S; Muraoka H; Saito Y; Kobayashi I; Hibi T
Digestion; 2009; 79(1):1-4. PubMed ID: 19142036
[TBL] [Abstract][Full Text] [Related]
27. Proton pump inhibitor therapy and Helicobacter pylori infection: a complicated relationship.
McColl K
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):185-6. PubMed ID: 16930290
[No Abstract] [Full Text] [Related]
28. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
[TBL] [Abstract][Full Text] [Related]
29. [Yeast-like fungi in the gastric mucus at acid-dependent disease].
Lazebnik LB; Khomeriki SG; Morozov IA; Kas'ianenko VI; Zvenigorodskaia LA; Khomeriki NM; Goncharenko LS
Eksp Klin Gastroenterol; 2005; (4):27-32. PubMed ID: 16255534
[No Abstract] [Full Text] [Related]
30. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
31. From Nobel to no cure: a case for monitoring antibiotic resistance in the gastric pathogen Helicobacter pylori.
Chisholm SA; Owen RJ
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):349-51. PubMed ID: 16771610
[No Abstract] [Full Text] [Related]
32. [Genetic type of Helicobacter pylori and the efficacy of eradication therapy].
Parzecka M; Szaflarska-Popławska A; Mierzwa G; Gorzkiewicz M; Łuczak S; Grzybowski T
Pol Merkur Lekarski; 2009 Feb; 26(152):105-9. PubMed ID: 19388513
[TBL] [Abstract][Full Text] [Related]
33. Pylera for the eradication of Helicobacter pylori infection.
Saleem A; Qasim A; O'Connor HJ; O'Morain CA
Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
[TBL] [Abstract][Full Text] [Related]
34. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
35. [The role of genetic features of Helicobacter pylori in pathogenesis of digestive system diseases: from theory to practice].
Baryshnikova NV; Suvorov AN; Tkachenko EI; Uspenskiĭ IuP
Eksp Klin Gastroenterol; 2009; (1):12-9. PubMed ID: 19548418
[TBL] [Abstract][Full Text] [Related]
36. The A2143G point mutation of clarithromycin resistance affects Helicobacter pylori eradication.
De Francesco V; Zullo A; Ierardi E; Giorgio F; Perna F; Hassan C; Panella C; Vaira D
J Clin Gastroenterol; 2009 Apr; 43(4):386. PubMed ID: 19077730
[No Abstract] [Full Text] [Related]
37. Mucolytics and Helicobacter pylori eradication.
Guslandi M
Helicobacter; 2003 Feb; 8(1):79; author reply 79-80. PubMed ID: 12603620
[No Abstract] [Full Text] [Related]
38. [Helicobacter pylori infection: what to do after first intent treatment failure?].
Delchier JC
Rev Prat; 2008 Sep; 58(13):1442-4. PubMed ID: 18924328
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis: the effect of supplementation with lactoferrin on eradication rates and adverse events during Helicobacter pylori eradication therapy.
Zou J; Dong J; Yu XF
Helicobacter; 2009 Apr; 14(2):119-27. PubMed ID: 19298339
[TBL] [Abstract][Full Text] [Related]
40. [New era of Helicobacter pylori].
Perez Perez GI
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():31-2. PubMed ID: 17471853
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
